YHB Investment Advisors Inc. Has $1.49 Million Stock Holdings in Cigna Group $CI

Key Points

• YHB Investment Advisors Inc. increased its holdings in Cigna Group by 98.5% in the second quarter, resulting in a valuation of approximately $1.49 million for their 4,493 shares.
• Cigna Group reported quarterly earnings of $7.20 per share, surpassing estimates, with revenue rising 11.0% year-over-year, totaling about $67.13 billion.
• The company also declared a quarterly dividend of $1.51 per share, equating to an annual yield of 2.1% and a payout ratio of 32.97%.

YHB Investment Advisors Inc. lifted its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 98.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,493 shares of the health services provider's stock after acquiring an additional 2,230 shares during the quarter. YHB Investment Advisors Inc.'s holdings in Cigna Group were worth $1,485,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Flaharty Asset Management LLC purchased a new stake in shares of Cigna Group in the 1st quarter worth $28,000. 1248 Management LLC purchased a new stake in Cigna Group during the first quarter worth about $29,000. Activest Wealth Management boosted its stake in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares during the period. Retirement Wealth Solutions LLC boosted its holdings in shares of Cigna Group by 74.1% in the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock worth $33,000 after buying an additional 43 shares during the period. Finally, Putney Financial Group LLC bought a new position in shares of Cigna Group during the fourth quarter valued at $36,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Performance

CI stock traded up $3.18 during trading on Tuesday, hitting $291.80. The company had a trading volume of 324,148 shares, compared to its average volume of 1,797,077. Cigna Group has a 1-year low of $256.89 and a 1-year high of $358.88. The firm has a market cap of $77.89 billion, a PE ratio of 15.91, a price-to-earnings-growth ratio of 0.85 and a beta of 0.48. The firm has a 50-day moving average price of $293.71 and a 200-day moving average price of $311.30. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same quarter in the previous year, the business posted $6.72 earnings per share. The firm's quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts expect that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were issued a $1.51 dividend. The ex-dividend date was Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.1%. Cigna Group's payout ratio is 32.97%.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 28,526 shares of the company's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company's stock, valued at $7,694,400. This represents a 52.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Guggenheim reiterated a "buy" rating and issued a $350.00 target price (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the company a "buy" rating in a report on Tuesday, August 5th. Barclays lifted their target price on shares of Cigna Group from $354.00 to $383.00 and gave the company an "overweight" rating in a report on Thursday, September 4th. Wells Fargo & Company lowered their target price on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and issued a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $371.81.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.